These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20948386)

  • 1. Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy.
    Murri R; Cingolani A; De Luca A; Di Giambenedetto S; Marasca G; De Matteis G; Mazzoccato V; Fabbiani M; Pinnetti C; Tamburrini E
    J Acquir Immune Defic Syndr; 2010 Nov; 55(3):411-2. PubMed ID: 20948386
    [No Abstract]   [Full Text] [Related]  

  • 2. Profile of adherence to highly active antiretroviral therapy of patients older than 50 years old.
    Pardi GR; Nunes AA; Preto R; Canassa PG; Correia D
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):301-3. PubMed ID: 20118680
    [No Abstract]   [Full Text] [Related]  

  • 3. Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals.
    Murri R; Guaraldi G; Lupoli P; Crisafulli R; Marcotullio S; von Schloesser F; Wu AW
    AIDS Patient Care STDS; 2009 Jan; 23(1):35-9. PubMed ID: 19183079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.
    Cicconi P; Cozzi-Lepri A; Castagna A; Trecarichi EM; Antinori A; Gatti F; Cassola G; Sighinolfi L; Castelli P; d'Arminio Monforte A;
    HIV Med; 2010 Feb; 11(2):104-13. PubMed ID: 19732176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study.
    Ekstrand ML; Chandy S; Heylen E; Steward W; Singh G
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):415-6. PubMed ID: 20190588
    [No Abstract]   [Full Text] [Related]  

  • 8. How long is the right interval for assessing antiretroviral pharmacy refill adherence?
    Acri TL; Grossberg RM; Gross R
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):e16-8. PubMed ID: 20647824
    [No Abstract]   [Full Text] [Related]  

  • 9. Is antiretroviral therapy adherence substantially worse on weekends than weekdays?
    Bachhuber M; Bilker WB; Wang H; Chapman J; Gross R
    J Acquir Immune Defic Syndr; 2010 May; 54(1):109-10. PubMed ID: 20418726
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measure of effectiveness and adherence to antiretroviral therapy in HIV-infected patients in Cameroon].
    Mahy S; Duong M; Huraux JM; Aurenche C; Ndong JG; Birguel J; Piroth L; Chavanet P
    Med Mal Infect; 2011 Apr; 41(4):176-80. PubMed ID: 20650582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing clinic retention between residents and nonresidents of Kibera, Kenya.
    Chung MH; Kohler P; Attwa M; Thiga J; John-Stewart GC
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):422-4. PubMed ID: 20190592
    [No Abstract]   [Full Text] [Related]  

  • 12. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
    Bijker R; Jiamsakul A; Kityo C; Kiertiburanakul S; Siwale M; Phanuphak P; Akanmu S; Chaiwarith R; Wit FW; Sim BL; Boender TS; Ditangco R; Rinke De Wit TF; Sohn AH; Hamers RL
    J Int AIDS Soc; 2017 Mar; 20(1):21218. PubMed ID: 28362063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia.
    Chan PY; Joseph MA; Des Jarlais DC; Uusküla A
    Int J STD AIDS; 2018 Jan; 29(1):13-22. PubMed ID: 28618981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1).
    Burack G; Gaur S; Marone R; Petrova A
    J Pediatr Nurs; 2010 Dec; 25(6):500-4. PubMed ID: 21035017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and Evolution of Antiretroviral Therapy Adherence Among Perinatally HIV-Infected Adolescents in Brazil.
    Côté J; Delmas P; de Menezes Succi RC; Galano E; Auger P; Sylvain H; Colson S; Machado DM
    J Adolesc Health; 2016 Sep; 59(3):305-310. PubMed ID: 27320032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups.
    Dworkin MS; Douglas GW; Sabitha Rani GP; Chakraborty A
    Int J STD AIDS; 2016 Mar; 27(3):186-95. PubMed ID: 25801316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to Antiretroviral Therapy in Turkey: Results from the ACTHIV-IST Study Group.
    Yildiz Sevgi D; Gunduz A; Altuntas Aydin O; Mete B; Sargin F; Kumbasar Karaosmanoglu H; Uzun N; Yemisen M; Dokmetas I; Tabak F
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1192-1198. PubMed ID: 28854809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study.
    Miller LG; Liu H; Hays RD; Golin CE; Ye Z; Beck CK; Kaplan AH; Wenger NS
    Clin Infect Dis; 2003 Feb; 36(4):514-8. PubMed ID: 12567311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.
    Navarro J; Pérez M; Curran A; Burgos J; Feijoo M; Torrella A; Caballero E; Ocaña I; Ribera E; Crespo M; Falcó V
    AIDS Patient Care STDS; 2014 Oct; 28(10):537-42. PubMed ID: 25111167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential antiretroviral adherence measurement using electronic bottle cap monitors in a cohort of HIV-infected adults.
    Shuter J; Sarlo JA; Stubbs RO; Rode RA; Zingman BS
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):94-7. PubMed ID: 22223595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.